Table 2.
Laboratory results during certoparin therapy in all study patients (n = 62)
| Baseline | 12 h | 24 h | P-value | |
| Prothrombin (%) | 87 ± 14 | 88 ± 13 | 90 ± 14 | 0.240 |
| aPTT (sec) | 39 ± 9 | 38 ± 7 | 38 ± 7 | 0.183 |
| Antithrombin (%) | 73 ± 17 | 75 ± 17 | 77 ± 17 | 0.006a |
| Fibrinogen (mg/dl) | 497 ± 198 | 529 ± 201 | 551 ± 211 | <0.001a |
| Hemoglobin (g/dl) | 10.2 ± 1.3 | 10.3 ± 1.3 | 10 ± 1.1 | 0.221 |
| Platelets (g/l) | 189 ± 103 | 183 ± 96 | 199 ± 119 | 0.055 |
| Serum creatinine (mg/dl) | 1.35 ± 0.85 | - | 1.41 ± 0.95 | 0.536 |
| Serum urea (mg/dl) | 67 ± 40 | - | 72 ± 42 | 0.072 |
a, significant time effect.
PT, Prothrombin Time; aPTT, activated Partial Thromboplastin Time; AT, Antithrombin; -, not measured,
Data are given as mean values ± SD.